ダウンロード数: 36
このアイテムのファイル:
| ファイル | 記述 | サイズ | フォーマット | |
|---|---|---|---|---|
| ccr3.4859.pdf | 405.91 kB | Adobe PDF | 見る/開く |
| タイトル: | Successful treatment of COVID‐19‐related acute respiratory distress syndrome with a rare blood type: A case report |
| 著者: | Yamada, Hiroyuki    https://orcid.org/0000-0002-5167-3147 (unconfirmed)Ohtsuru, Shigeru https://orcid.org/0000-0002-6747-9859 (unconfirmed)Nagatomo, Mika Korogi, Yohei Shinozuka, Ken Tanabe, Naoya https://orcid.org/0000-0002-7481-0212 (unconfirmed)Kai, Shinichi Matsubara, Takeshi Ito, Isao https://orcid.org/0000-0003-3109-898X (unconfirmed)Ihara, Masahiro Tanaka, Tomoharu Kato, Genta Nagao, Miki https://orcid.org/0000-0002-8886-6145 (unconfirmed)Date, Hiroshi |
| 著者名の別形: | 山田, 博之 大鶴, 繁 長友, 美佳 興梠, 陽平 篠塚, 健 田辺, 直也 甲斐, 慎一 松原, 雄 伊藤, 功朗 井原, 正裕 田中, 具治 加藤, 源太 長尾, 美紀 伊達, 洋至 |
| キーワード: | AKI ARDS COVID-19 ECMO hydrocortisone rhesus |
| 発行日: | Sep-2021 |
| 出版者: | Wiley |
| 誌名: | Clinical Case Reports |
| 巻: | 9 |
| 号: | 9 |
| 論文番号: | e04859 |
| 抄録: | Extracorporeal membrane oxygenation is indispensable for critically severe COVID-19 patients. However, it would be inapplicable to patients with a rare blood type or blood transfusion refusal. In that case, severely conservative fluid management with the sacrifice of renal functions and hydrocortisone therapy should be considered for better oxygenation. |
| 著作権等: | © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
| URI: | http://hdl.handle.net/2433/277488 |
| DOI(出版社版): | 10.1002/ccr3.4859 |
| PubMed ID: | 34594554 |
| 出現コレクション: | 学術雑誌掲載論文等 |
このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス
